KRT7 and neoplasm: The immunohistochemical result (IHC), carried out in June 2021, highlighted the following: CK 7 zonal positive; CK 20 negative; TTF1 negative; CD 10 positive on extended areas of the tumor; positive zonal VIM; P 63 negative; CDX 2 inconclusive; KI 67 positive in 20%.